LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 65.70 | 84.90 | 798 | 8484 | 0.0941 | 0.4012 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 65.70 | 84.90 | 5367 | 8484 | 0.6326 | 0.8668 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 67.41 | 84.90 | 380 | 8766 | 0.0433 | 0.2511 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 67.41 | 84.90 | 5035 | 8766 | 0.5744 | 0.8409 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 67.41 | 84.90 | 810 | 8766 | 0.0924 | 0.4010 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 67.41 | 84.90 | 5426 | 8766 | 0.6190 | 0.8616 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 69.11 | 84.90 | 396 | 8988 | 0.0441 | 0.2573 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 69.11 | 84.90 | 5221 | 8988 | 0.5809 | 0.8448 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 69.11 | 84.90 | 824 | 8988 | 0.0917 | 0.4020 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 69.11 | 84.90 | 5617 | 8988 | 0.6249 | 0.8650 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.81 | 84.90 | 394 | 9132 | 0.0431 | 0.2554 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.81 | 84.90 | 5293 | 9132 | 0.5796 | 0.8447 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.81 | 84.90 | 811 | 9132 | 0.0888 | 0.3971 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.81 | 84.90 | 5739 | 9132 | 0.6285 | 0.8670 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 72.52 | 84.90 | 409 | 9214 | 0.0444 | 0.2618 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 72.52 | 84.90 | 5420 | 9214 | 0.5882 | 0.8490 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 72.52 | 84.90 | 835 | 9214 | 0.0906 | 0.4022 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 72.52 | 84.90 | 5917 | 9214 | 0.6421 | 0.8732 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.22 | 84.90 | 410 | 9343 | 0.0439 | 0.2614 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.22 | 84.90 | 5591 | 9343 | 0.5984 | 0.8542 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.22 | 84.90 | 858 | 9343 | 0.0918 | 0.4065 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.22 | 84.90 | 6031 | 9343 | 0.6455 | 0.8750 | MN20160318_Q02 | N21 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 75.93 | 84.90 | 408 | 8970 | 0.0455 | 0.2630 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 75.93 | 84.90 | 5765 | 8970 | 0.6427 | 0.8727 | MN20160318_Q02 | E22 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 75.93 | 84.90 | 779 | 8970 | 0.0868 | 0.3905 | MN20160318_Q02 | N21 |